These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nonconvulsive status epilepticus due to a de novo contralateral focus during tiagabine adjunctive therapy. Imperiale D; Pignatta P; Cerrato P; Montalenti E; Ravetti C; Benna P Seizure; 2003 Jul; 12(5):319-22. PubMed ID: 12810347 [TBL] [Abstract][Full Text] [Related]
23. Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria. Piccinelli P; Borgatti R; Perucca E; Tofani A; Donati G; Balottin U Epilepsia; 2000 Nov; 41(11):1485-8. PubMed ID: 11077464 [TBL] [Abstract][Full Text] [Related]
24. [Experience with tiagabine in the clinical practice; new insights as to the efficacy and safety profile]. Kellinghaus C; Loddenkemper T; Weitemeyer L; Lüdemann P Nervenarzt; 2001 Oct; 72(10):764-9. PubMed ID: 11688177 [TBL] [Abstract][Full Text] [Related]
25. Status epilepticus and tiagabine therapy revisited. Koepp MJ; Edwards M; Collins J; Farrel F; Smith S Epilepsia; 2005 Oct; 46(10):1625-32. PubMed ID: 16190934 [TBL] [Abstract][Full Text] [Related]
26. Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Shinnar S; Berg AT; Treiman DM; Hauser WA; Hesdorffer DC; Sackellares JC; Leppik I; Sillanpaa M; Sommerville KW Epilepsia; 2001 Mar; 42(3):372-9. PubMed ID: 11442155 [TBL] [Abstract][Full Text] [Related]
27. Non-convulsive status epilepticus associated with tiagabine therapy in children. Skardoutsou A; Voudris KA; Vagiakou EA Seizure; 2003 Dec; 12(8):599-601. PubMed ID: 14630501 [TBL] [Abstract][Full Text] [Related]
28. Propofol in status epilepticus: little evidence, many dangers? Niermeijer JM; Uiterwaal CS; Van Donselaar CA J Neurol; 2003 Oct; 250(10):1237-40. PubMed ID: 14586609 [TBL] [Abstract][Full Text] [Related]
29. Tiagabine overdose: a case of status epilepticus in a non-epileptic patient. Fulton JA; Hoffman RS; Nelson LS Clin Toxicol (Phila); 2005; 43(7):869-71. PubMed ID: 16440516 [TBL] [Abstract][Full Text] [Related]
30. Propofol in the treatment of convulsive status epilepticus: a report of four cases. Campostrini R; Bati MB; Giorgi C; Palumbo P; Serra P; Vinattieri A; Cantini A; Martini E Riv Neurol; 1991; 61(5):176-9. PubMed ID: 1808675 [TBL] [Abstract][Full Text] [Related]
31. Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus. Rison RA; Ko DY Clin Neurol Neurosurg; 2009 Jul; 111(6):558-61. PubMed ID: 19395155 [TBL] [Abstract][Full Text] [Related]
32. [Case of amoxapine-induced refractory status epilepticus which was successfully treated with propofol]. Ide A Chudoku Kenkyu; 2006 Oct; 19(4):407-8. PubMed ID: 17133983 [No Abstract] [Full Text] [Related]
33. Review of the evidence for the use of propofol in the management of status epilepticus. Hirsch NP; Smith M J Neurol; 2003 Oct; 250(10):1241. PubMed ID: 14586610 [No Abstract] [Full Text] [Related]
34. Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Rossetti AO; Oddo M; Liaudet L; Kaplan PW Neurology; 2009 Feb; 72(8):744-9. PubMed ID: 19237704 [TBL] [Abstract][Full Text] [Related]
35. Tiagabine withdrawal-emergent mania. Pushpal D; Shamshul HN Aust N Z J Psychiatry; 2006 Aug; 40(8):719. PubMed ID: 16866771 [No Abstract] [Full Text] [Related]